Business Description
Aura Biosciences is a Boston-based clinical-stage company focused on developing targeted treatments for solid tumors. It uses a proprietary technology that attaches drugs or genetic material to virus-like particles, allowing them to seek out and attack cancer cells with greater precision. Its lead drug candidate, bel-sar, is being tested in advanced trials for eye melanoma and other eye cancers, as well as in earlier trials for bladder cancer.
